Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters

NCT00396253 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00396253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
October 31, 2008
Enrollment
223 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dysfunctional hemodialysis catheters